JENNIFER MESSINA: Open Payments
NPI 1730734914 · NORTH VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,498 in 138 payments from 44 companies in 2025. Trend: 2023 $3,285 · 2024 $3,251 · 2025 $3,498
Food & beverage: $2,913Education: $585
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $269 |
| Ipsen Biopharmaceuticals, Inc | 4 | $244 |
| Janssen Biotech, Inc. | 8 | $244 |
| PFIZER INC. | 9 | $202 |
| Daiichi Sankyo Inc. | 7 | $197 |
| SEAGEN INC. | 2 | $195 |
| Incyte Corporation | 7 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 8 | $138 |
| BeOne Medicines USA, Inc. | 8 | $131 |
Products named: Enhertu, OJJAARA, BRUKINSA, JAKAFI, KEYTRUDA, Trodelvy, REBLOZYL, Nubeqa.
Industry payments across FL — which companies pay providers there.
